| Literature DB >> 34062828 |
Mansour Ghasemikaram1, Klaus Engelke2, Matthias Kohl3, Simon von Stengel1, Wolfgang Kemmler1.
Abstract
The present study aimed to determine the effect of detraining on muscle quality (MQ) in older men with osteosarcopenia. Forty-three community-dwelling older men (78 ± 4 years) were randomly allocated to a consistently supervised high-intensity resistance exercise training (HIRT) group (n = 21) or a control group (CG, n = 22). The HIRT scheduled a periodized single set protocol twice weekly. After the intervention, the men were subjected to six months of detraining. Muscle quality (MQ), defined as maximum isokinetic hip/leg extensor strength per unit of mid-thigh intra-fascia volume, was determined by magnetic resonance imaging (MRI) or per unit of thigh muscle mass assessed by dual-energy X-ray absorptiometry (DXA). Intention-to-treat analysis with multiple imputations was applied. We observed significant exercise effects for MQ (p = 0.001). During detraining, the HIRT group lost about one-third of the intervention-induced gain and displayed significantly (p = 0.001) higher MQ reductions compared to the CG. Nevertheless, after training and detraining, the overall intervention effect on MQ remained significant (p ≤ 0.004). In summary, six months of absence from HIRT induce a significant deleterious effect on MQ in older osteosarcopenic men. We conclude that intermitted training programs with training breaks of six months and longer should be replaced by largely continuous exercise programs, at least when addressing MQ parameters.Entities:
Keywords: detraining; exercise training; muscle mass; muscle strength; resistance training
Year: 2021 PMID: 34062828 PMCID: PMC8147362 DOI: 10.3390/nu13051528
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
Figure 1Flowchart of the FrOST study. CG, control group; HIRT, high-intensity resistance exercise training.
Baseline characteristics (i.e., before detraining) of the participants of the exercise and control group. CG: control group; EG: exercise group.
| Variable | CG ( | HIRT ( |
|---|---|---|
| Age (years) | 80.8 ± 4.7 | 79.6 ± 3.6 |
| Body mass index (kg/m2) | 24.6 ± 2.1 | 24.8 ± 3.0 |
| Total body fat (%) | 32.2 ± 5.5 | 33.5± 4.3 |
| More than two diseases ( | 13 | 9 |
| Metabolic syndrome ( | 12 | 9 |
| Diabetes mellitus type II ( | 1 | 1 |
| Habitual physical activity (Index) b | 4.32 ± 1.44 | 4.51 ± 1.27 |
| Exercise volume (min/week) | 54 ± 56 | 52 ± 50 |
| 25-OHD level (ng/mL) c | 29.6 ± 5.8 | 28.1 ± 5.8 |
| Calcium intake (mg/d) | 852 ± 266 | 827 ± 291 |
| Energy intake (kcal/d) d | 2242 ± 639 | 2197 ± 508 |
| Dietary protein intake (g/kg/d) d | 1.25 ± 0.23 | 1.15 ± 0.27 |
a according to the International Diabetes Federation; b scale from (1) “very low” to (7) “very high”; c 25-hydroxy-vitamin D, ECLIA; Roche Diagnostics, Penzberg, Germany; d as determined by a 4 day dietary record.
Baseline values and mean changes ± standard error (SE) of muscle quality (MILES/intra-fascia volume and MILES/thigh mass) as determined by MRI and DXA in the HIRT and CG after training and detraining.
| Baseline | Δ Training a | Δ Detraining b | Δ Overall a | ||
|---|---|---|---|---|---|
| MILES/intra-fascia volume (N/cm3) | CG | 1.55 (0.07) | 0.01 (0.05) | 0.04 (0.04) | 0.05 (0.04) |
| HIRT | 1.47 (0.11) | 0.49 (0.05) | −0.18 (0.05) | 0.30 (0.05) | |
|
| 0.54 | 0.001 |
|
| |
| MILES/thigh LBM (N/kg) | CG | 195 (10) | 1.8 (4.8) | 0.5 (3.2) | 2.2 (2.9) |
| HIRT | 176 (13) | 50.5 (4.6) | −14.0 (3.8) | 36.5 (5.1) | |
|
| 0.25 | 0.001 |
|
|
a changes from baseline; b changes from training (i.e., 18 month FU). Bold: effects related to the primary (detraining effects) and secondary (final effects after detraining) hypothesis. CG, control group; HIRT, high-intensity resistance exercise training; LBM, lean body mass; MILES: maximum bilateral isokinetic hip/-leg-extension strength.